To strengthen these findings, we employed a murine model of asthma progression, demonstrating that TSLP levels in lung tissue, BALF, and serum were significantly elevated during the chronic asthma stage but decreased in remission, reinforcing its potential relevance as a biomarker for asthma trajectory assessment. Here, TSLP is linked to asthma.